- Pharma Tech Industries appoints Darrin T. Schellin as its new CEO, bringing over 20 years of industry experience.
- Schellin previously served as CEO of GBI Bio, where he transitioned the company into a full-service CDMO.
Pharma Tech Industries, a global provider of contract manufacturing and packaging services, has named Darrin T. Schellin as its new Chief Executive Officer. With over two decades of experience in the healthcare and pharmaceutical sectors, Schellin will lead the company through its next growth phase, focusing on expanding service offerings and geographical reach.
“We are thrilled to welcome Darrin to Pharma Tech Industries,” said Tee Noland, Chairman of the Board. “His strategic vision and operational expertise make him the ideal leader to guide our company into the future.”
Schellin brings a wealth of experience from his previous role as CEO at GBI Bio, where he played a pivotal role in transforming the organisation from a clinical phase CDMO to a full-service clinical and commercial biotech CDMO. His background aligns with Pharma Tech’s long-term goals of growth and partnership-building.
Schellin expressed his enthusiasm for joining the company, stating, “I am honoured to join Pharma Tech Industries at such an exciting time. I look forward to building on the company’s impressive legacy and continuing to deliver best-in-class solutions to our partners.”
